Latest period
$25.86B
YoY change
+11.3%
5Y CAGR
+9.6%
Peak year (2025)
$24.23B
Latest annual
$24.23B
Total Equity history chart for Boston Scientific (BSX) from 1991 to 2025
Latest: $24.23B
Total Equity growth chart for Boston Scientific (BSX) from 1991 to 2025
Latest: +11.3%
Total Equity history table for Boston Scientific (BSX) from 1991 to 2025
| 2025 | $24.23B | +11.3% | +$2.46B | ||
| 2024 | $21.77B | +12.9% | +$2.49B | ||
| 2023 | $19.28B | +9.7% | +$1.71B | ||
| 2022 | $17.57B | +5.7% | +$951.00M | ||
| 2021 | $16.62B | +8.5% | +$1.30B | ||
| 2020 | $15.33B | +10.4% | +$1.45B | ||
| 2019 | $13.88B | +59.0% | +$5.15B | ||
| 2018 | $8.72B | +24.4% | +$1.71B | ||
| 2017 | $7.01B | +4.1% | +$278.00M | ||
| 2016 | $6.73B | +6.5% | +$413.00M | ||
| 2015 | $6.32B | -7.6% | −$523.00M | ||
| 2014 | $6.84B | +4.6% | +$304.00M | ||
| 2013 | $6.54B | -4.8% | −$331.00M | ||
| 2012 | $6.87B | -39.5% | −$4.48B | ||
| 2011 | $11.35B | +0.5% | +$57.00M | ||
| 2010 | $11.30B | -8.2% | −$1.00B | ||
| 2009 | $12.30B | -6.4% | −$837.00M | ||
| 2008 | $13.14B | -13.0% | −$1.96B | ||
| 2007 | $15.10B | -1.3% | −$201.00M | ||
| 2006 | $15.30B | +257.3% | +$11.02B | ||
| 2005 | $4.28B | +6.4% | +$257.00M | ||
| 2004 | $4.03B | +40.6% | +$1.16B | ||
| 2003 | $2.86B | +16.0% | +$395.00M | ||
| 2002 | $2.47B | +22.4% | +$452.00M | ||
| 2001 | $2.02B | +4.1% | +$80.00M | ||
| 2000 | $1.94B | +12.2% | +$211.00M | ||
| 1999 | $1.72B | +110.0% | +$902.90M | ||
| 1998 | $821.10M | -16.7% | −$165.10M | ||
| 1997 | $986.20M | +7.6% | +$69.90M | ||
| 1996 | $916.30M | +21.7% | +$163.30M | ||
| 1995 | $753.00M | +121.5% | +$413.00M | ||
| 1994 | $340.00M | +37.8% | +$93.30M | ||
| 1993 | $246.70M | -1.0% | −$2.40M | ||
| 1992 | $249.10M | +175.9% | +$158.80M | ||
| 1991 | $90.30M | — | — |
- 2025$24.23B+11.3%
- 2024$21.77B+12.9%
- 2023$19.28B+9.7%
- 2022$17.57B+5.7%
- 2021$16.62B+8.5%
- 2020$15.33B+10.4%
- 2019$13.88B+59.0%
- 2018$8.72B+24.4%
- 2017$7.01B+4.1%
- 2016$6.73B+6.5%
- 2015$6.32B-7.6%
- 2014$6.84B+4.6%
- 2013$6.54B-4.8%
- 2012$6.87B-39.5%
- 2011$11.35B+0.5%
- 2010$11.30B-8.2%
- 2009$12.30B-6.4%
- 2008$13.14B-13.0%
- 2007$15.10B-1.3%
- 2006$15.30B+257.3%
- 2005$4.28B+6.4%
- 2004$4.03B+40.6%
- 2003$2.86B+16.0%
- 2002$2.47B+22.4%
- 2001$2.02B+4.1%
- 2000$1.94B+12.2%
- 1999$1.72B+110.0%
- 1998$821.10M-16.7%
- 1997$986.20M+7.6%
- 1996$916.30M+21.7%
- 1995$753.00M+121.5%
- 1994$340.00M+37.8%
- 1993$246.70M-1.0%
- 1992$249.10M+175.9%
- 1991$90.30M—
Total Equity values are taken from Boston Scientific's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Equity at Boston Scientific (BSX)
According to Boston Scientific's latest reported financial statements, the company's latest reported total equity is $25.86B. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Boston Scientific (BSX) most recent annual total equity stands at $24.23B (2025) – grew 11.3% year-over-year.
Boston Scientific total equity has grown for 10 consecutive years, with a +9.6% compound annual growth rate over 2020–2025 (5 years).
$24.23B stands as the all-time-high annual total equity, posted in 2025, against a low of $90.30M during 1991.
Boston Scientific Total Equity by Year
Boston Scientific Total Equity 2025: $24.23B
2025's total equity for Boston Scientific came in at $24.23B, grew 11.3% from 2024. This figure represents the highest annual value in the available history.
Boston Scientific Total Equity 2024: $21.77B
Boston Scientific posted total equity of $21.77B in 2024, grew 12.9% from 2023.
Boston Scientific Total Equity 2023: $19.28B
In 2023, Boston Scientific reported total equity of $19.28B, grew 9.7% from 2022.
Boston Scientific Total Equity 2022: $17.57B
Boston Scientific total equity in 2022 was $17.57B, grew 5.7% from 2021.
Boston Scientific Total Equity 2021: $16.62B
Boston Scientific total equity in 2021 was $16.62B.
See more financial history for Boston Scientific (BSX).
Sector peers by Total Equity
Healthcare peers of Boston Scientific (BSX), ranked by their latest total equity
| $94.11B | |
| $81.54B | |
| $52.61B | |
| $48.67B | |
| $30.52B | |
| $26.54B | |
| $8.66B | |
| −$3.27B |
- $94.11B
- $81.54B
- $52.61B
- $48.67B
- $30.52B
- $26.54B
- $8.66B
- −$3.27B
Frequently asked questions
Boston Scientific (BSX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation